SamuelAJacobsMD
Oncology • Pittsburgh, PABreast Cancer, Gastrointestinal Cancer, Hematologic Oncology
NSABP Foundation
Dr. Jacobs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
Pittsburgh, PA 15232Phone+1 412-235-1020Fax+1 412-235-1030
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1974 - 1976
UPMC Medical EducationResidency, Internal Medicine, 1971 - 1973
University of Rochester School of Medicine and DentistryClass of 1971
Certifications & Licensure
PA State Medical License 1976 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma Start of enrollment: 2003 Nov 01
Publications & Presentations
PubMed
- 202 citationsctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.Arvind Dasari, Van K. Morris, Carmen J. Allegra, Chloe E. Atreya, Al B. Benson
Nature Reviews. Clinical Oncology. 2020-07-06 - 105 citationsIn situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behaviorAlejandra Carvajal-Cuenca, Luz F. Sua, Nhora M. Silva, Nhora M. Silva, Stefania Pittaluga
Haematologica. 2012-02-01 - 5 citationsA Putative Case of Methotrexate-Related Lymphoma: Clinical Course and PET/CT FindingsRachel C. Jankowitz, James Ganon, Todd M Blodgett, Christine Garcia, Samuel A. Jacobs
Case Reports in Medicine. 2009-12-23
Press Mentions
Generex Announces Collaboration with Merck to Evaluate KEYTRUDA® (Pembrolizumab) in Combination with AE37 in Patients with Triple-Negative Breast CancerJuly 31st, 2017
Grant Support
- Core--Clinical Research Services Clinical Trials OfficeNational Cancer Institute2005–2008
- Core--Protocol Review And Monitoring SystemNational Cancer Institute2004–2008
- Cancer Center Model For Early Phase Clinical TrialsNational Cancer Institute2003–2005
- Clinical Research Services Clinical Trials OfficeNational Cancer Institute2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
